Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Biomarker/Laboratory analysis, Treatment
Completed
18 and over
Pharmaceutical / Industry
CR005278
NCT00265135
Last Modified:
7/10/2007
 
First Published:
3/27/2006
2.
Phase II Study of CNTO 328 in Patients With Unresectable or Metastatic Renal Cell Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
SWOG-S0351
S0351, NCT00311545
3.
A Study of the Safety and Efficacy of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer (HRPC)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Temporarily closed
18 and over
Pharmaceutical / Industry
CR012346
C0328T07, NCT00385827
Last Modified:
5/3/2008
 
First Published:
2/5/2007
4.
Phase II Study of Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Hormone-Refractory Metastatic Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
SWOG-S0354
S0354, NCT00433446
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute